One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood.v128.22.1107.1107
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 35 |
Affiliation: Memorial Sloan Kettering Cancer Center, University of Bologna, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Jewish General Hospital, Manchester Academic Health Science Centre, University of Manchester, Institut Gustave Roussy, National and Kapodistrian University of Athens, Nagoya University Hospital, University Hospital Cologne, MSD (United States), City Of Hope National Medical Center
Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
